Skip to content

BIOLIFE SOLUTIONS INC

Delisted

CIK 834365fmd_0JPM53P1C1WE8Q2QZEW7MY6V20Manufacturing · Electromedical & Electrotherapeutic ApparatusTemplate: Standard

Coverage: Jan 01, 2010 to Jun 30, 2026, 65 periods

Latest annual · FY2025

Millions
Total revenues
96
Gross profit
62
Operating income
(17)
Net income
(5)
Free cash flow
11

Latest quarter · Q2 FY2026

Millions
Total revenues
28
Gross profit
18
Operating income
2
Net income
45
Free cash flow
5
Open Financials

Key stats

Open Analysis

Compound annual growth

Revenue, 3 yearsFY2022 to FY2025
+8.1%
Revenue, 5 yearsFY2020 to FY2025
+14.9%
Net income, 5 yearsFY2020 to FY2025
n/m

BIOLIFE SOLUTIONS INC financials: quick answers

Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.

MetricFY2025FY2024ChangeSource
Revenue$96.2 million$74.6 million+28.9%10-K 2026-02-26 · proof
Gross profit$62.1 million$50.1 million+24%10-K 2026-02-26 · proof
Operating income-$16.6 million-$4.5 million10-K 2026-02-26 · proof
Net income-$4.6 million-$20.2 million10-K 2026-02-26 · proof
Cash from operating activities$20.1 million$8.4 million+138.6%10-K 2026-02-26 · proof
Free cash flow$10.6 million$5.2 million+104.4%10-K 2026-02-26 · proof
Total assets$405.9 million$399.5 million+1.6%10-K 2026-02-26 · proof
Total liabilities$34 million$50.6 million-32.8%10-K 2026-02-26 · proof
Cash and cash equivalents$33 million$91.5 million-63.9%10-K 2026-02-26 · proof
Total debt$5 million$15.9 million-68.7%10-K 2026-02-26 · proof
What was BIOLIFE SOLUTIONS INC's revenue in fiscal 2025?
BIOLIFE SOLUTIONS INC reported revenue of $96.2 million for fiscal 2025 (the year ended Dec 31, 2025), against $74.6 million the year before (+28.9%). Source: the 10-K filed with the SEC on Feb 26, 2026. SEC
What was BIOLIFE SOLUTIONS INC's gross profit in fiscal 2025?
BIOLIFE SOLUTIONS INC reported gross profit of $62.1 million for fiscal 2025 (the year ended Dec 31, 2025), against $50.1 million the year before (+24%). Source: the 10-K filed with the SEC on Feb 26, 2026. SEC
What was BIOLIFE SOLUTIONS INC's operating income in fiscal 2025?
BIOLIFE SOLUTIONS INC reported operating income of -$16.6 million for fiscal 2025 (the year ended Dec 31, 2025), against -$4.5 million the year before. Source: the 10-K filed with the SEC on Feb 26, 2026. SEC
What was BIOLIFE SOLUTIONS INC's net income in fiscal 2025?
BIOLIFE SOLUTIONS INC reported net income of -$4.6 million for fiscal 2025 (the year ended Dec 31, 2025), against -$20.2 million the year before. Source: the 10-K filed with the SEC on Feb 26, 2026. SEC
What was BIOLIFE SOLUTIONS INC's cash from operating activities in fiscal 2025?
BIOLIFE SOLUTIONS INC reported cash from operating activities of $20.1 million for fiscal 2025 (the year ended Dec 31, 2025), against $8.4 million the year before (+138.6%). Source: the 10-K filed with the SEC on Feb 26, 2026. SEC
What was BIOLIFE SOLUTIONS INC's free cash flow in fiscal 2025?
BIOLIFE SOLUTIONS INC reported free cash flow of $10.6 million for fiscal 2025 (the year ended Dec 31, 2025), against $5.2 million the year before (+104.4%). Source: the 10-K filed with the SEC on Feb 26, 2026. SEC
What are BIOLIFE SOLUTIONS INC's total assets?
As of Dec 31, 2025, BIOLIFE SOLUTIONS INC reported total assets of $405.9 million, against $399.5 million a year earlier (+1.6%). Source: the 10-K filed with the SEC on Feb 26, 2026. SEC
What are BIOLIFE SOLUTIONS INC's total liabilities?
As of Dec 31, 2025, BIOLIFE SOLUTIONS INC reported total liabilities of $34 million, against $50.6 million a year earlier (-32.8%). Source: the 10-K filed with the SEC on Feb 26, 2026. SEC
What are BIOLIFE SOLUTIONS INC's cash and cash equivalents?
As of Dec 31, 2025, BIOLIFE SOLUTIONS INC reported cash and cash equivalents of $33 million, against $91.5 million a year earlier (-63.9%). Source: the 10-K filed with the SEC on Feb 26, 2026. SEC
What is BIOLIFE SOLUTIONS INC's total debt?
As of Dec 31, 2025, BIOLIFE SOLUTIONS INC reported total debt of $5 million, against $15.9 million a year earlier (-68.7%). Source: the 10-K filed with the SEC on Feb 26, 2026. SEC

Read from the FinancialMD API on Nov 13, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.

The same numbers for an agent, with proof on every value:

curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=cik:834365&period_type=annual&limit=5"

Information only, not investment advice.